Health | FUJIFILM Holdings Corporation

Fulfill Unmet Medical Needs (Priority Issue 1)

Targets for FY2030	Major activities of FY2023	Self- evalution
Develop and disseminate new treatments based on regenerative medicine and cell therapy	Investment of USD 200 million in two subsidiaries in the U.S. to significantly expand global cell therapy contract development and manufacturing capabilities Launched FUJIFILM Diosynth Biotechnologies Japan to provide contract development and manufacturing service of biopharmaceuticals in Japan and Asia FUJIFILM Cellular Dynamics and Opsis Therapeutics granted BlueRock Therapeutics a license to develop and commercialize an iPSC-derived cell therapy candidate for the treatment of human retinal diseases.	〇

Learn more

Improve Accessibilities to Medical Services (Priority Issue 2)

Targets for FY2030	Major activities of FY2023	Self- evalution
(1) Reducing burden on medical professionals by utilizing IT	Built a next-generation cloud management platform for the Japan Medical Image Database (J-MID) in collaboration with Japan Radiological Society and Juntendo University Began offering a new version of its AI platform, SYNAPSE SAI viewer, which supports doctors' image diagnostic workflows, called SYNAPSE SAI viewer Ver2.3. Launched the digital mammography system “AMULET SOPHINITY,” which achieves lower dosage, higher resolution and improved workflow through AI technology. Project for promoting tuberculosis screening using X-ray portable systems in India. Provided training programs of image analysis and diagnostic technology to improve the capabilities of Egyptian medical technicians. Introduced our AI-driven products and services to 100 countries (Achieved the targets by FY2023)	〇
(2) Development and dissemination of infectious disease diagnostic system to contribute to global health
(3) Offering technical diagnosis training and spreading effective health practices to emerging countries
(4) Improve medical accessibility by introducing our AI-driven products/services to all 196 countries throughout the world

Learn more

Efforts to End Tuberculosis

Contribute to Early Disease Detection (Priority Issue 3)

Targets for FY2030	Major activities of FY2023	Self- evalution
Launch health screening centers (Target) 30 centers in FY2026 100 centers in FY2030 Reduce the physical burden through widespread and expanded use of medical diagnostic systems	Launched health screening centers focusing on cancer : 5 centers New centers launched in FY 2023 are in Hyderabad, India and in Ulaanbaatar, Mongolia Launched multi-slice CT system “FCT iStream” which contributes to the streamlining of inspection workflows and reducing inspection times.	〇

Efforts to End Tuberculosis

Contribute to Health Promotion and Beauty (Priority Issue 4)

Targets for FY2030	Major activities of FY2023	Self- evalution
(1) Promote to prolong healthy lives	Launched HIZATEKUTO, the first foods with functional claims^1 in Japan, which displays the function of supporting the production of cartilage components and helping to protect joint cartilage Launched ASTALIFT ADVANCED LOTION, which contains a moisturising ingredient that penetrate the skin well^2 with finely dispersed in petrolatum using our unique nano technology 1 Confirmed by the Consumer Affairs Agency's ‘Search for Notified Information on Foods with Function Claims’ in Japan. 2 ‘Penetrate’ means right down to the skin's horny layer. ‘well’ means in comparison with our products.	〇
(2) Promote support for women’s empowerment

Targets for FY2030

Major activities of FY2023

Self-
evalution

(1) Promote to prolong healthy lives

Launched HIZATEKUTO, the first foods with functional claims^*1 in Japan, which displays the function of supporting the production of cartilage components and helping to protect joint cartilage
Launched ASTALIFT ADVANCED LOTION, which contains a moisturising ingredient that penetrate the skin well^*2 with finely dispersed in petrolatum using our unique nano technology

*1 Confirmed by the Consumer Affairs Agency's ‘Search for Notified Information on Foods with Function Claims’ in Japan.
*2 ‘Penetrate’ means right down to the skin's horny layer. ‘well’ means in comparison with our products.

〇

(2) Promote support for women’s empowerment

Promote Management of a Healthy Workplace (Priority Issue 5)

Targets for FY2030	Major activities of FY2023	Self- evalution
Promote management of health and productivity to maintain employees’ vitality	At the employee health screening facility ‘Fujifilm Mediterrace Yokohama’ in Japan, a full-body screening service began in June 2023, and CT scans began in January 2024 Selected for the Health and Productivity Stock Selection Program for 4th consecutive year Health Management e-Learning “Understanding the menopause, self-care and mental healthcare” for Fujifilm Group employees in Japan Held a company-wide walking event with the health insurance association and employee organizations. 35 (spring) and 37 (autumn) group companies participated	〇

Data and Information：Employee Overview

PDF：2.59MB

Learn more

Future Activities and Targets

We will continue to make capital investments in our bio-CDMO and life science businesses and provide one-stop value as a company that supports the creation of cutting-edge biopharmaceuticals.

In the medical systems business, we will continue to develop and provide a variety of products and services that meet the needs of the medical field and contribute to the development of medical care worldwide and the maintenance and improvement of people's health by positioning medical IT at the core of our business and linking each product group based on medical imaging, picture archiving and communication systems (PACS). We will also contribute to solving the issue of eliminating medical disparities through our unique solutions, such as NURA, a health screening service business in India, and tuberculosis screening using portable X-ray equipment.

Furthermore, in promoting health management, we will accelerate efforts to maintain and improve the health of employees throughout the Group in the five priority areas (lifestyle-related diseases, smoking, cancer, mental health, and long working hours), and to achieve our mid-term goal by FY2025, thereby contributing to the realization of a healthy society with longevity.

Activities of each operating company

Initiatives for Occupational Health and Safety (Fujifilm)

Learn more